TF and cancer: Given that ovarian cancer patients have a high incidence of VTE at distant sites from neoplastic tissue (Tateo et al, 2005; Satoh et al, 2007), cancer cell-derived TF-fVIIa-positive MPs may have a function in intravascular thrombosis in such patients.